Loading...

Defense Modernization And Aerospace Recovery Will Reshape Markets

Published
16 Sep 24
Updated
29 Apr 26
Views
125
29 Apr
US$142.92
AnalystConsensusTarget's Fair Value
US$146.60
2.5% undervalued intrinsic discount
Loading
1Y
112.5%
7D
-5.7%

Author's Valuation

US$146.62.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 29 Apr 26

Fair value Increased 2.37%

DCO: Defense Backlog And Vision 2032 Framework Will Steady Fair Outlook

Ducommun's updated fair value estimate has moved from $143.20 to $146.60 as analysts factor in a series of higher price targets tied to defense exposure, missile program visibility, and recent margin and backlog trends.

Analyst Commentary

Recent Street research on Ducommun centers on defense exposure, missile program visibility, and margin execution, which together are feeding into higher fair value estimates and revised price targets.

Bullish Takeaways

  • Bullish analysts highlight record Q4 revenue of US$216M and EBITDA of US$38M, along with a US$1.2b backlog, as support for Ducommun’s ability to execute on current programs and sustain its order book.
  • Several research notes point to expanding gross margins of 27.7% and EBITDA margins of 17.5% as a key driver behind higher price targets, linking margin performance to improved earnings power over time.
  • Defense exposure, including long term agreements on key missile programs, is cited as a major source of visibility. Bullish analysts see this as important for supporting premium valuation multiples compared with weaker visibility profiles.
  • References to the planned five year “Vision 2032” framework and focus on proprietary products and free cash flow are viewed positively, with analysts treating this as a sign of disciplined execution priorities rather than pure top line growth.

Bearish Takeaways

  • Bearish analysts trimming price targets point to mixed Q4 results, suggesting that execution is not uniformly strong across all segments and could create volatility around quarterly earnings delivery.
  • Flat aerospace expectations for 2026 and tempered commercial aerospace trends tied to 737 MAX destocking are seen as limiting near term growth in that part of the portfolio. This may cap upside if defense programs do not offset softer areas.
  • The reliance on future acceleration in 2027 and 2028 in some research commentary introduces timing risk, with cautious analysts flagging that any delay in missile program ramps or destocking normalization could pressure valuation assumptions.
  • With multiple price target changes both higher and lower, some analysts signal that the risk reward profile is sensitive to small shifts in backlog quality, margin progress, and the pace of execution on restructuring and product mix goals.

Valuation Changes

  • Fair Value, updated from $143.20 to $146.60, has risen slightly and indicates a modest upward adjustment in the intrinsic value estimate.
  • Discount Rate, edged up from 7.80% to 7.91% and reflects a small increase in the required return input used in the valuation model.
  • Revenue Growth, updated from 7.52% to 7.53%, shows a very small change in the long term growth assumption applied to Ducommun’s revenue base.
  • Net Profit Margin, adjusted from 8.86% to 8.86%, is essentially unchanged, with only a marginal shift in the modeled profitability level.
  • Future P/E, moved from 29.63x to 30.42x, and indicates a slightly higher multiple being applied to forward earnings assumptions.
1 viewusers have viewed this narrative update

Key Takeaways

  • Expansion in defense and commercial aerospace, driven by rising demand and modernization, positions Ducommun for sustained top-line growth and increased order activity.
  • Strategic focus on higher-margin products, automation, and domestic sourcing is improving margins, cash flow stability, and overall earnings quality.
  • Heavy dependence on volatile aerospace and defense markets, operational execution challenges, and uncertainty in acquisitions threaten Ducommun's revenue growth, margin stability, and diversification efforts.

Catalysts

About Ducommun
    Provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States.
What are the underlying business or industry changes driving this perspective?
  • Elevated global defense spending and the replenishment of missile and radar inventories-highlighted by strong double-digit growth in both segments and a 30% increase in missile backlog-positions Ducommun to sustain and expand revenue as defense modernization accelerates over the next several years, with increasing program content and order activity.
  • Strengthening demand for commercial aircraft, particularly with increasing Boeing 737 and 787 build rates and projected end to destocking in 2025/2026, underpins a likely recovery and longer-term rebound in top-line growth for Ducommun's commercial aerospace business.
  • Ongoing mix shift toward higher-margin engineered products and aftermarket (maintained at 23% of revenues, moving toward 25%+), together with value-driven pricing and restructuring actions, is increasing gross margins (recorded at 26.6% in Q2), which supports sustained improvements in net margins and earnings.
  • Facility consolidations, automation, and digital initiatives expected to generate $11-13 million in annual savings (with full benefits ramping in late 2025–2026), set the stage for further operating margin expansion and better cash flow conversion (targeting 100% in the coming years).
  • Minimal exposure to tariff impacts, and high percentage of domestic production and sourcing, should allow Ducommun to capitalize on the industry-wide shift toward supply chain localization, potentially capturing increased market share and stabilizing contract flows, thereby reducing earnings volatility and supporting stable free cash flow.
Ducommun Earnings and Revenue Growth

Ducommun Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Ducommun's revenue will grow by 7.5% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -4.1% today to 8.9% in 3 years time.
  • Analysts expect earnings to reach $90.8 million (and earnings per share of $5.62) by about April 2029, up from -$33.9 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 31.1x on those 2029 earnings, up from -63.2x today. This future PE is lower than the current PE for the US Aerospace & Defense industry at 36.0x.
  • Analysts expect the number of shares outstanding to grow by 0.73% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.91%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Ducommun continues to face significant cyclical risk connected to commercial aerospace customers like Boeing and Spirit AeroSystems; persistent destocking and uncertain ramp-up timelines introduce volatility in aerospace revenue, which could negatively impact top-line growth in low-demand cycles.
  • There is a growing concentration of revenue from the defense sector, especially missile and radar programs, exposing the company to shifts in U.S. government defense budgets and platform priorities-potentially impacting both revenue and margin stability if defense spending slows or focus shifts away from Ducommun's key franchises.
  • Execution risks associated with facility consolidation, product line recertification, and transitioning work to new or lower-cost locations (such as the ramp-up at Coxsackie and Guaymas) may lead to unforeseen production delays, temporary operating inefficiencies, or customer disruptions, adversely affecting near
  • and mid-term margins and earnings.
  • Ducommun's ability to scale up its higher-margin engineered product and aftermarket portfolio partly hinges on successful and timely acquisitions; intensifying competition for quality assets or delayed/integrated acquisitions could slow margin expansion and inhibit revenue diversification, limiting the pace of long-term earnings growth.
  • Sustained pressure from unfavorable sales mix (as seen in lower Structural Systems margins) and ongoing restructuring costs, combined with reliance on favorable product mix for margin gains, may challenge the company's ability to consistently expand net margins and achieve targeted profitability if market or execution tailwinds weaken.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $146.6 for Ducommun based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.0 billion, earnings will come to $90.8 million, and it would be trading on a PE ratio of 31.1x, assuming you use a discount rate of 7.9%.
  • Given the current share price of $143.11, the analyst price target of $146.6 is 2.4% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Ducommun?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives